ZEALAND PHARMA A/S revenue breakdown overview

ZEALAND PHARMA A/S revenue for the last year amounted to 62.70 M DKK, the most of which — 62.69 M DKK — came from its highest performing source at the moment, Peptide-based Medicines, the year earlier bringing 342.79 M DKK. The greatest contribution to the revenue figure was made by Denmark — last year it brought ZEALAND PHARMA A/S 62.28 M DKK, and the year before that — 44.19 M DKK.